Patients with unresectable colorectal cancer and 10+ liver metastases experience notable survival benefits from hepatic resection combined with radiofrequency ablation (RFA) and systemic therapy. Three-year survival rates soar to 39.2% for surgery approaches, compared to just 18.6% and 8.2% for RFA plus systemic therapy and systemic therapy alone, respectively. This retrospective cohort study analyzes 373 patients, emphasizing the importance of assessing surgical options in this high-risk group.
Journal Article by Lu P, Li Y (…) Peng J et 2 al. in J Gastrointest Oncol
Copyright © 2025 AME Publishing Company. All rights reserved.